A complete, sustained response of mCRPC to treatment with ABT-888

A newly published report in Frontiers in Oncology is likely to be of considerable interest to many patients currently battling progressive and advanced forms of prostate cancer … but we emphasize that its promise may be limited to a relatively small subset of such patients. … READ MORE …